Inhibition of nuclear factor-kappa B (NF-κB) activation attenuates ureteric damage in obstructive uropathy

Pharmacological Research

Volumn 60, Issue 4, 2009, Pages 347-357

  Chuang, Yen Hwang ^a,b   Chuang, Wan Long ^a,b   Huang, Shu Pin ^a,b   Liu, Ching Kuan ^a,b   Huang, Chun Hsiung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

NF B; NF B inhibitor; Obstructive uropathy; Ureter

Indexed keywords

CYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; HYDROURETER; NONHUMAN; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RAT; SMOOTH MUSCLE FIBER; URETER LIGATION;

ANIMALS; ANTIOXIDANTS; FEMALE; NF-KAPPA B; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; THIOCARBAMATES; URETER; URETERAL OBSTRUCTION;

EID: 69249230970     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.05.004     Document Type: Article

References (37)

1. Guijarro C., and Egido J. Transcription factor-κB (NFκB) and renal disease. Kidney Int 59 (2001) 415-424
2. Chen F., Castranova V., Shi X., and Demers L.M. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of disease. Clin Chem 45 (1999) 7-17
3. Chosh S., and Hayden M.S. New regulators of NF-κB in inflammation. Nature 8 (2008) 837-848
4. Winther M.P.J., Kanters E., Kraal G., and Hofker M.H. Nuclear factor κB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25 (2005) 904-914
5. Cude K., Wang Y., Choi H.J., Hsuan S.L., Zhang H., Wang C.Y., et al. Regulation of the G2-M cell cycle progression by the ERK5-NFκB signaling pathway. J Cell Biol 177 (2007) 253-264
6. Pahl H.L. Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18 (1999) 6853-6866
7. Chen F., Castranova V., and Shi X. New insights into the role of nuclear factor-kB in cell growth regulation. Am J Pathol 159 (2001) 387-397
8. Perkins N.D. Integrating cell-signalling pathways with NFκB and IKK function. Nature 8 (2007) 49-62
9. Barkett M., and Gilmore T.D. Control of apoptosis by Rel/NFκB transcription factors. Oncogene 18 (1999) 6910-6924
10. Ruiz-Deya G., Sikka S.C., Thomas R., and Abdel-Mageed A.B. Potential role for the nuclear transcription factor-kappa B in the pathogenesis of ureteropelvic junction obstruction. J Endourol 16 (2002) 611-615
11. Munoz C., Pascual-Salcedo D., Castellanos M.C., Alfranca A., Aragones J., Vara A., et al. Pyrrolidine dicarbamate inhibits the production of interleukin-6, interleukin-8 and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediator: modulation of NF-κB and AP-1 transcription factors activity. Blood 88 (1996) 3482-3490
12. Palanki M.S. Inhibitors of AP-1 and NF-κappa B mediated transcription activation: therapeutic potential in autoimmune diseases and structural diversity. Curr Med Chem 9 (2002) 219-227
13. Heinrich P.C., Behrman I., Haan S., Hermanns H., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374 (2003) 1-20
14. Pais Jr. V.M., Strandhoy J.W., and Assimos D.G. Pathophysiology of urinary tract obstruction. In: Wein A.J., Kavoussi L.R., Novick A.C., Partin A.W., and Peters C.A. (Eds). Campbell-Walsh urology (2007), Elsevier Saunders, Philadelphia 1195-1226
15. Miyajima A., Kosaka T., Seta K., Asano T., Umezawa K., and Hayakawa M. Novel nuclear factor kB activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 169 (2003) 1559-1563
16. Tashiro K., Tamada S., Kuwabara N., Komiya T., Takekida K., Asai T., et al. Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor κB. Int J Mol Med 12 (2003) 587-592
17. Haase M.G., Klawitter A., Geyer P., Alheit H., Baumann M., Kriegel T.M., et al. Sustained elevation of NF-κB DNA-binding activity in radiation-induced lung damage in rat. Int J Radiat Biol 79 (2003) 863-877
18. Cuzzocrea S., Chatterjee P.K., Mazzon E., Dugo L., Serraina I., Britti D., et al. Pyrrolidine dicarbamate attenuates the development of acute and chronic inflammation. Brit J Pharmacol 135 (2002) 496-510
19. Tamada S., Nakatani T., Asai T., Tashiro K., Komiya T., Sumi T., et al. Inhibition of nuclear factor kB activation by pyrrolidine dicarbamate prevents chronic FK506 nephropathy. Kidney Int 63 (2003) 306-314
20. Chuang Y.H., Chuang W.L., Liu K.M., Chen S.S., and Huang C.H. Tissue damage and regeneration of the ureteric smooth muscle in rat with obstructive uropathy. Brit J Urol 82 (1998) 261-266
21. Chuang Y.H., Chuang W.L., Chen S.S., and Huang C.H. Expression of transforming growth factor-β1 and its receptors related to the ureteric fibrosis in a rat model of obstructive uropathy. J Urol 163 (2000) 1298-1303
22. Hsu S.M., and Raine L. The use of avidin-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In: Delellis R.A. (Ed). Advances in immunohistochemistry (1984), Year Book Medical, Chicago 31-43
23. Chuang Y.H., Chuang W.L., and Huang C.H. Myocyte apoptosis in the pathogenesis of ureteral damage in rats with obstructive uropathy. Urology 58 (2001) 463-470
24. Gurbuzer N., Yurtcu M., Findik S., Avunduk M.C., and Gunel E. Investigation of histopathologic changes in the ureter walls in experimental congenital obstructive uropathy. J Pediatr Surg 43 (2008) 1524-1527
25. Yurtcu M., Gurbuzer N., Findik S., Avunduk M.C., and Gunel E. Investigation of histopathologic changes in the ureter walls in vesicoureteral reflux. J Pediatr Surg 44 (2009) 802-805
26. Bruck R., Schey R., Hochman A., Genina O., and Pines M. A protective effect of pyrrolidine dicarbamate in a rat model of liver cirrhosis. Liver Int 24 (2004) 169-176
27. Kuwabara N., Tamada S., Iwai T., Teramoto K., Kaneda N., Yukimura T., et al. Attenuation of renal fibrosis by curcumin in rat obstructive nephrology. Urology 67 (2006) 440-446
28. Chtterjee P.K., Villa Bianca R.E., Sivarajah A., McDonald M.C., Cuzzocrea S., et al. Pyrrolidine dicarbamate reduces renal dysfunction and injury caused by ischemia/reperfusion of the rat kidney. Eur J Pharmacol 482 (2003) 271-280
29. Lawrance I.C., Wu F., Leite A.Z.A., Willis J., West G.A., Fiocchi C., et al. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-κB. Gastroenterology 125 (2003) 1750-1761
30. Cummins E.P., and Taylor C.T. Hypoxia-responsive transcription factors. Pflugers Arch 450 (2005) 363-371
31. Leahy A.L., Ryan P.C., McEnttee G.M., Nelson A.C., and Fitzpatrick J.M. Renal injury and recovery in partial ureteric obstruction. J Urol 142 (1989) 199-203
32. Sack M.N., Smith R.M., and Opie L.H. Tumor necrosis factor in myocardial hypertrophy and ischemia-an anti-apoptotic perspective. Cardiovasc Res 45 (2000) 688-695
33. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
34. Yu C.C.W., and Filipe M.I. Update on proliferation-associated antibodies applicable formaline-fixed paraffin-embedded tissue and their clinical applications. Histochem J 25 (1993) 843-853
35. Ohtani K., Egashira K., Nakano K., Zhao G., Funakoshi K., Ihara Y., et al. Stent-based local delivery of nuclear factor-κB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits. Circulation 114 (2006) 2773-2779
36. Bellas R.E., Lee J.S., and Sonenshein G.E. Expression of constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle. J Clin Invest 96 (1995) 2521-2527
37. Chuang Y.H., Chuang W.L., Huang S.P., and Huang C.H. Cyclooxygenase-2 inhibitor ameliorates ureteric damage in rats with obstructed uropathy. Eur J Pharmacol 569 (2007) 126-137